$1.570
-0.039 (-2.48%)Zum Schluss
RPID-News
RPID-Events
Company Reports Q2 Revenue of $8.05M, Beating Expectations
Reports Q2 revenue $8.05M, consensus $7.88M. "Our second quarter results reflect continued execution against the strategic and financial priorities we outlined at the beginning of the year," said Robert Spignesi, President and CEO. "Total revenue increased 11%, recurring revenue grew 14% and consumables achieved quarterly records in both units and revenue. Importantly, we delivered record second-quarter total gross margin of 15%, marking a positive inflection that reflects meaningful progress against our margin expansion initiatives and supports our path to positive cash flow."
Raises FY26 System Validation View to At Least 27 Validations
Raises FY26 system validation view to at least 27 validations from 25 validations. Spignesi continued, "As we look to the second half of 2026, we remain encouraged by strong customer engagement, continued momentum in multi-system and enterprise deployment opportunities, and an expanding contribution from our collaboration with MilliporeSigma. Combined with favorable industry tailwinds, including increased adoption of automation and ongoing U.S. reshoring and biomanufacturing capacity expansion, we believe we are well positioned to achieve our full-year objectives and enter 2027 with positive momentum."
Lake Street Lowers Rapid Micro Price Target to $7
Lake Street lowered the firm's price target on Rapid Micro Biosystems to $7 from $8 and keeps a Buy rating on the shares after the company announced an underwritten public offering and concurrent registered direct offering with upfront gross proceeds of about $9.8M and potential additional gross proceeds of about $21.7M if the accompanying warrants are exercised in cash. The firm lowered its price target to reflect the increase in share count resulting from the financing.
Company Reports Q1 Revenue of $8.0M, Exceeding Expectations
Reports Q1 revenue $8.0M, consensus $7.6M. Cash, cash equivalents, short-term investments, and restricted cash were approximately $23M as of March 31. "Our first quarter results reflect strong and consistent execution across the business," said Robert Spignesi, CEO. "Strong consumable revenue drove nearly 30% growth in recurring revenue, underscoring the strength of our installed base and utilization trends. We continue to see robust customer interest in QC automation and are increasingly engaged in strategic discussions with customers on enterprise-level deployments of the Growth Direct platform and broader integration into company-wide automation strategies."
Company Reaffirms FY26 Total Revenue Guidance of $37M-$41M
The company reaffirmed its FY26 total revenue guidance range of $37.0M-$41.0M including a range of 30 to 38 Growth Direct system placements, at least 25 system validations and gross margin percentage of approximately 20%.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.